Verge Genomics is a company that develops a drug discovery platform for neurodegenerative diseases. It was founded in 2015 by Alice Zhang and Jason Chen. Verge Genomics has received funding from OS Fund, WuXi AppTec, and ALS Investment Fund. The company is headquartered in San Francisco, California, United States.
Products and services
Verge Genomics's computational biology and artificial intelligence platform is able to generate novel drug compounds to target genes involved in neurodegenerative diseases. The platform is designed to construct new therapeutics for diseases that are caused by multiple gene anomalies. The company uses datasets collected from human tissue samples of patients with diseases such as Parkinson's and amyotrophic lateral sclerosis (ALS). Several new therapeutics for ALS developed by Verge Genomics have passed preclinical trials.
Verge Genomics raises a $32,000,000 series A round from Agent Capital, ALS Investment Fund, DFJ, OS Fund and WuXi AppTec Corporate Venture fund.
Documentaries, videos and podcasts
- BiotechnologyBiotechnology can refer to the application of science and technology to living organisms or the use of living organisms, their parts, products or models thereof to solve a problem, produce knowledge or produce goods and services. Biotechnology may involve the alteration of living or non-living materials.
- CompanyA company, abbreviated 'co.', is a legal entity made up of an association of people, be they natural, legal, or a mixture of both, for carrying on a commercial or industrial enterprise.